Hong Kong–listed China Innovation Investment Limited released its Monthly Return for the period ending 31 August 2026, confirming that both authorised and issued share capital remained unchanged during the month.

Authorised / Registered Share Capital • Authorised capital stood at 100 billion ordinary shares with a par value of HKD 0.01, equating to HKD 1.00 billion. No changes were recorded versus July 2026.

Issued Share Capital and Public Float • Issued shares totalled 12.80 billion, with no treasury shares on record. • The company affirmed compliance with the Main Board’s minimum public-float requirement of 25%.

Share Option Position • No new shares were issued through option exercises in August. • Outstanding share options under the 2018, 2020 and 2023 grants totalled 90.00 million units, each carrying an exercise price of HKD 0.0497. – 2018 grant (4 April 2018): 30.00 million options outstanding. – 2020 grant (14 April 2020): 30.00 million options outstanding. – 2023 grant (29 September 2023): 30.00 million options outstanding, with a further 12.60 million shares still available for future grant under the scheme.

Warrants, Convertibles and Other Equity Instruments • The company reported no outstanding warrants, convertible securities, or other share-issuing arrangements during the month.

Governance Confirmation • The board confirmed that all share capital movements, where applicable, complied with Hong Kong Listing Rules and relevant regulatory requirements.

Overall, China Innovation Investment’s August filing highlights a stable capital structure with no equity dilution during the month and maintains full compliance with public-float thresholds.